Trial Profile

F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (IND 123119, Protocol D

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 23 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Flortaucipir-F-18 (Primary)
Indications Alzheimer's disease; Dementia
Focus Diagnostic use
Acronyms AV ADAD; DIAN

Most Recent Events

17 Jul 2024 Planned End Date changed from 1 Sep 2024 to 1 Sep 2025.
17 Jul 2024 Planned primary completion date changed from 1 Mar 2024 to 1 Mar 2025.
29 Jun 2021 Study design is changed from open, interventional to masked roles unspecified and observational. Phase is changed from phase 2 to not specified.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com